ATIVESITE | #Survodutide : More #Mounjaro Competition Incoming from @boehringeringelheim!!!
SERVODUTIDE: Is an investigational co-agonist (GLP-1/Glucagon) incretin treatment from @boehringeringelheim , and it is showing very promising results!
Read All About it: https://www.boehringer-ingelheim.com/human-health/metabolic-diseases/obesity/phase-ii-clinical-trial-weight-loss-results
👀 Find me everywhere + more community at:
https://www.onthepen.com
On The Pen Marketing:
https://www.onthepenmarketing.com
🥳 Join The Emoji Party! Become a member 🙂:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
📲 Contact Me: MounjaroMan@gmail.com
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
👩 Women’s Hair loss Product: https://amzn.to/3qrl3lr
👉 Link to other GLP-1 MUST HAVE products I mention:
https://www.amazon.com/shop/manonthemounjaroonthepen
🆓 FREE MOUNJARO:
Actively Recruiting Tirzepatide Studies:
https://clinicaltrials.gov/search?term=Tirzepatide&aggFilters=status:rec
🆓 FREE RETATRUTIDE:
Actively Recruiting Retatrutide Studies:
https://clinicaltrials.gov/search?term=retatrutide&aggFilters=status:rec
Source Boehringer Ingelheim YouTube
